This article outlines strategies insurers can use to mitigate their risks related to prescription opioid abuse by members, while addressing this serious public health problem.
Lisa McElhaney, BS
Advertisement
Articles by Lisa McElhaney, BS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
5 Things to Know About Retatrutide, the "Trillion-Dollar" Drug
2
Iberdomide Approval Elevates MRD’s Role in Myeloma: Prerna Mewawalla, MD
3
Retina Specialists Favor Efficacy Over Risk in Geographic Atrophy Care
4
ICER Draft Flags High Cost of New Hypertension Drug Class
5